ACLARA BioSciences Conference Call Notice; Thursday, July 20, 2000 10:30 a.m. ET, 7:30 a.m. PT.Business Editors/Health & Medical Writers MOUNTAIN VIEW, Calif.--(BW HealthWire)--July 19, 2000 ACLARA BioSciences (Nasdaq:ACLA ACLA American Comparative Literature Association (Austin, TX) ACLA All China Lawyers Association (China) ACLA American Coalition of Life Activists (anti-abortion group) ) will conduct a conference call with investors at 10:30 a.m. ET (7:30 a..m. PT) on Thursday Thursday: see week. , July 20, 2000 to discuss the Markman ruling in ACLARA's '015 patent infringement patent infringement n. the manufacture and/or use of an invention or improvement for which someone else owns a patent issued by the government, without obtaining permission of the owner of the patent by contract, license or waiver. suit. A news release discussing this ruling was issued on Wednesday, July 19 after the market closed. Participating in the ACLARA conference call will be: Joseph M. Limber, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , ACLARA BioSciences Michael W. Hunkapiller, Ph.D., Board Member, ACLARA BioSciences and President, PE Biosystems If you would like to listen to this conference call, please call 1-888-946-8412. The reservation number for the call is 7507196. If you are unable to listen to the call at the scheduled time In rallying, the Scheduled Time of any crew is the time, calculated at the beginning of the event, that they should arrive at any given control. It is different from Due Time in that Due Time is dynamic, ie it can change throughout the event as competitors drop time; whereas , you will be able to access a recording of the call immediately following the call until July 28 by dialing 1-402-998-0631 and using the reservation number 7507196. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion